EPISODE · Feb 23, 2020 · 30 MIN
Humans 2.0 (with Fuz Rana)
from Think Biblically: Conversations on Faith & Culture · host Fuz Rana, Sean McDowell, Scott Rae
New developments in biotechnology promise breakthroughs that could improve people’s lives, but also threaten to enhance human beings and alter human nature. Biochemist Fazale (Fuz) Rana opens a window to the new world of human enhancement technologies and the movement of transhumanism (transcending human nature) in this stimulating conversation. Biochemist Dr. Fazale (Fuz) Rana writes and speaks extensively about evidence for creation emerging from biochemistry, genetics, human origins, and synthetic biology. As vice president of research and apologetics at Reasons to Believe (RTB), he is dedicated to communicating to skeptics and believers alike the powerful scientific case for God's existence and the Bible's reliability. Read a transcript of this episode at: https://www.biola.edu/blogs/think-biblically/2020/humans-2-0 ==========Think Biblically: Conversations on Faith and Culture is a podcast from Talbot School of Theology at Biola University, which offers degrees both online and on campus in Southern California. Find all episodes of Think Biblically at: https://www.biola.edu/think-biblically. To submit comments, ask questions, or make suggestions on issues you'd like us to cover or guests you'd like us to have on the podcast, email us at [email protected].
What this episode covers
New developments in biotechnology promise breakthroughs that could improve people’s lives, but also threaten to enhance human beings and alter human nature. Biochemist Fazale (Fuz) Rana opens a window to the new world of human enhancement technologies and the movement of transhumanism (transcending human nature) in this stimulating conversation. Biochemist Dr. Fazale (Fuz) Rana writes and speaks extensively about evidence for creation emerging from biochemistry, genetics, human origin...
NOW PLAYING
Humans 2.0 (with Fuz Rana)
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m